North America Home Infusion Therapy Market - Key Players, Size, Trends, Opportunities, Growth Analysis to 2028
The North America home infusion therapy market is expected
to grow from US$ 10,954.08 million in 2022 to US$ 18,112.18 million by 2028. It
is estimated to grow at a CAGR of 8.7% from 2022 to 2028
Increasing Incidences of Chronic Disorders Coupled with Rising
Geriatric Population is Driving North America Home Infusion Therapy Market
Chronic disorders such as cardiovascular,
nutritional, and gastrointestinal disorders, rheumatoid arthritis, and
neurological disorders affect the overall quality of life.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@
https://www.businessmarketinsights.com/sample/BMIRE00028375
According to the World Health Organization
(WHO), over 50% of the global population is estimated to suffer from at least
one chronic disease. The Centers for Disease Control and Prevention (CDC)
stated that 6 out of 10 people in the US suffered from at least one chronic
disease in 2019. According to the “Worldwide Prevalence and Burden of
Functional Gastrointestinal Disorders, Results of Rome Foundation Global
Study,” a large-scale multinational study published in 2021, ~40% of 73,076
adults surveyed from 33 countries in the world were suffering from a functional
gastrointestinal disorder (GFID). Age-related gastrointestinal problems are
more common in the elderly population, aged 64 and above.
📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-home-infusion-therapy-market
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
B. Braun Melsungen AG
Baxter International Inc
Nipro Corp
Becton Dickinson and Co
Fresenius Kabi AG
ICU Medical Inc
JMS Co Ltd
Eitan Medical Ltd
Terumo Corp
Expanding Geriatric Population:
- Aging is associated with a decline in physiological
function, increasing susceptibility to chronic diseases.
- The global elderly population is growing rapidly. The
Global Ageing Survey 2019 indicates that the proportion of individuals
aged 65 and above is projected to increase from 1 in 11 in 2019 to 1 in 6
by 2025.
- In the United States, the number of Americans aged 65
and older is expected to more than double between 2016 and 2060, reaching
over 98 million.
- Globally the percentage of the elderly will grow from
15% to approximately 24% by 2060.
- This demographic shift, combined with the increased
prevalence of chronic diseases, is creating a substantial demand for home
infusion therapy, enabling patients to receive necessary treatments in the
comfort and convenience of their own homes.
𝐀𝐛𝐨𝐮𝐭
𝐔𝐬:
Business Market Insights is a market research platform that
provides subscription service for industry and company reports. Our research
team has extensive professional expertise in domains such as Electronics &
Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy
& Power; Healthcare; Manufacturing & Construction; Food &
Beverages; Chemicals & Materials; and Technology, Media, &
Telecommunications
𝐀𝐮𝐭𝐡𝐨𝐫’𝐬 𝐁𝐢𝐨:
𝐒𝐡𝐫𝐞𝐲𝐚 𝐏𝐚𝐰𝐚𝐫
𝐒𝐞𝐧𝐢𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭
𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
𝐄𝐱𝐩𝐞𝐫𝐭
Comments
Post a Comment